SCHEMBL15096867

SCHEMBL15096867

CCc1ccc(COCOC)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
TP53 P04637 1/20 0.39
TAAR1 Q96RJ0 1/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
TSHR P16473 2/20 0.37
CYP2A6 P11509 1/20 0.37
LPL P06858 1/20 0.37
LIPG Q9Y5X9 1/20 0.37
KCNH2 Q12809 1/20 0.36
MAPK1 P28482 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
IDO1 P14902 2/20 0.34
AGXT P21549 2/20 0.34
CA2 P00918 2/20 0.34
ATM Q13315 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MEN1 O00255 1/20 0.34
APAF1 O14727 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8750354 0.83 TSHR (0.52) ALDH1A1TDP1TP53TAAR1RXRA
SCHEMBL8709934 0.83 ALDH1A1 (0.48) ALDH1A1TDP1TP53LPLLIPG
SCHEMBL15452321 0.82 IDO1 (0.48) ALDH1A1TP53TAAR1L3MBTL1IDO1
SCHEMBL12523976 0.82 AGXT (0.52) TDP1TAAR1TSHRCYP2A6KCNH2
SCHEMBL2094813 0.80 TP53 (0.46) ALDH1A1TDP1TP53TAAR1RXRA
SCHEMBL4661955 0.80 IDO1 (0.50) ALDH1A1TAAR1RXRARXRBTSHR
SCHEMBL9806222 0.80 TSHR (0.37) ALDH1A1TDP1TSHRKCNH2L3MBTL1
SCHEMBL3127292 0.79 TSHR (0.64) ALDH1A1TDP1TSHRMAPK1L3MBTL1
SCHEMBL21725204 0.78 AGXT (0.48) TAAR1TSHRCYP2A6KCNH2IDO1
SCHEMBL16125550 0.78 TSHR (0.34) TDP1TP53TSHRKCNH2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11525094-B2 Methods of deoxygenating bio-based material and production of bio-based terephtalic acid and olefinic monomers STORA ENSO OYJ (FI) 2022-12-13 US disclosed
US-8952194-B2 Hydrogen treatment of impure tall oil for the production of aromatic monomers STORA ENSO OYJ (FI) 2015-02-10 US disclosed
US-8952194-B2 Hydrogen treatment of impure tall oil for the production of aromatic monomers STORA ENSO OYJ (FI) 2015-02-10 US disclosed
US-20130178650-A1 HYDROGEN TREATMENT OF IMPURE TALL OIL FOR THE PRODUCTION OF AROMATIC MONOMERS STORA ENSO OYJ (FI) 2013-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178650-A1 HYDROGEN TREATMENT OF IMPURE TALL OIL FOR THE PRODUCTION OF AROMATIC MONOMERS TDO2, THPO, HAAO ALDH1A1 4351/4885TDP1 2422/4885TP53 1483/4885
US-11525094-B2 Methods of deoxygenating bio-based material and production of bio-based terephtalic acid and olefinic monomers FASN, BMP6, SCD ALDH1A1 2293/4885TDP1 2857/4885TP53 3330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.